Zak’s Sunday Roast, 11th April, analysis of stocks, markets by traders and investors.

Grab a coffee, settle down and listen to the guy’s view – thoughts covering this week in the markets. New and exclusive to Share Talk

In this edition of “Sunday Roast,”  Zak talks to experienced and seasoned investors Phil Carroll, Albert Arthur and Kevin Hornsby regarding the past weeks’ movers and shakers, market sentiment.


Sunday Roast:

15s Phil’s week: MyHealthChecked (MHC), 33s Valereum Blockchain (VLRM), 3.19m Rambler Metals (RMM)
4.00m Albert’s Week: Valereum Blockchain
6.03m Zak on being too early in the market.
6.40m Albert on MHC
7.46m Novacyte (NCYT)
8.40m COVID stocks / Scancell (SCLP)
10.19m Zak on the new ISA week
11.00 Ed joins
11.45m Kevin’s week – MHC, Rambler (RMM), [email protected] Capital (SYME), Zoetic (ZOE)
16.35m Ed on people buying FastForward (FFWD) shares.
17.24m Zak on the Roast, MHC and Tiziana (TILS)
18.13m Ed on stock market discussion
19.38m FFWD’s investments/strategy: Kanabo (KNB), Cellular Goods (CBX)
22.00m Albert: What does FFWD actually do?
24.00m Ed on the FFWD focus
24.50m Ed on Bobby Axelrod
25.41m Phil: What does FFWD look for in investments? Yooma.
30.19m EMMAC

(The opinions expressed here are those of the author, a columnist for Share Talk.) is a purely journalistic website – Zak Mir is a member of the National Union of Journalists. There is no intention here of providing financial advice. It is recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.